K. Nakamaru

Oxazolone-induced colitis in BALB/C mice: a new method to evaluate the efficacy of therapeutic agents for ulcerative colitis.

S. Hatakeyama, R. Kojima, S. Kuroda, 2004, Journal of pharmacological sciences.

Development of novel simian immunodeficiency virus vectors carrying a dual gene expression system.

T. Nakajima, K. Terao, M. Hasegawa, 2000, Human gene therapy.

[Effect of mesalazine, an agent for the treatment of idiopathic inflammatory bowel disease, on reactive oxygen metabolites and LTB4 formation].

S. Kawase, M. Sato, K. Nakamaru, 1994, Nihon yakurigaku zasshi. Folia pharmacologica Japonica.

Antiulcer activities of glycyrrhetinic acid derivatives in experimental gastric lesion models.

T. Mori, K. Hirabayashi, K. Watanabe, 1989, Chemical & pharmaceutical bulletin.

Selective expression of beta 7 integrin on lymphocytes undergoing apoptosis in lymphoid tissues.

K. Terao, H. Akari, T. Nishida, 1998, Biochemical and biophysical research communications.

Interleukin 18 is a potent proliferative factor for intestinal mucosal lymphocytes in Crohn's disease.

T. Hibi, M. Ikeda, M. Kurimoto, 2000, Gastroenterology.